Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

(NY: )

N/A UNCHANGED
Last Price Updated: Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close -
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Neuralstem to Present at The Neuroscience Innovation Forum for BD&L and Investment in Therapeutics and Technology
Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced Karl Johe, Ph.D, chief science officer Neuralstem, will present at... 
From GlobeNewswire News Releases
Neuralstem Announces Presentation of Clinical Data for NSI-189 in Major Depressive Disorder at the Upcoming American College of Neuropsychopharmacology Annual Meeting
Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced that data from the Company’s Phase 2 study of NSI-189 in patients... 
From GlobeNewswire News Releases

Performance

More News

Read More
Neuralstem Announces the Appointment of Two New Members to the Board of Directors
From GlobeNewswire News Releases
Neuralstem Announces Proposed Public Offering of Common Stock and Warrants
From GlobeNewswire News Releases
Benzinga Pro's 5 Stocks To Watch Today
Tags PAY PME Trading Ideas
From Benzinga
Neuralstem Reports Last Subject Out in Phase 2 Trial of NSI-189 for Major Depressive Disorder
From GlobeNewswire News Releases
BRIEF-Neuralstem Inc appoints two members to its board
Tags companyNews
From Reuters: Company News
BRIEF-?CVI investments reports a 8.3 pct passive stake in Neuralstem
Tags companyNews
From Reuters: Company News
BRIEF-Neuralstem awarded grant by NIH to continue preclinical research into treatment for diabetic neuropathy
Tags companyNews
From Reuters: Company News
Mid-Afternoon Market Update: NASDAQ Down 1%; LendingTree Shares Spike Higher
Tags Benzinga Global FTR
From Benzinga
Mid-Day Market Update: ShoreTel Gains On Acquisition News; Neuralstem Shares Plunge
Tags Intraday Update CYH AZN
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.